Vtv Therapeutics Stock Return On Asset
VTVT Stock | USD 23.80 0.71 3.07% |
VTv Therapeutics fundamentals help investors to digest information that contributes to VTv Therapeutics' financial success or failures. It also enables traders to predict the movement of VTv Stock. The fundamental analysis module provides a way to measure VTv Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VTv Therapeutics stock.
Return On Assets is likely to drop to -1.93 in 2024. VTv | Return On Asset |
VTv Return On Asset Analysis
VTv Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current VTv Therapeutics Return On Asset | -0.72 |
Most of VTv Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VTv Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
VTv Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for VTv Therapeutics is extremely important. It helps to project a fair market value of VTv Stock properly, considering its historical fundamentals such as Return On Asset. Since VTv Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of VTv Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of VTv Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
VTv Total Assets
Total Assets |
|
Based on the latest financial disclosure, VTv Therapeutics has a Return On Asset of -0.7203. This is 91.77% lower than that of the Biotechnology sector and 96.95% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
VTv Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VTv Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VTv Therapeutics could also be used in its relative valuation, which is a method of valuing VTv Therapeutics by comparing valuation metrics of similar companies.VTv Therapeutics is currently under evaluation in return on asset category among related companies.
VTv Fundamentals
Return On Equity | -49.78 | ||||
Return On Asset | -0.72 | ||||
Current Valuation | 47.26 M | ||||
Shares Outstanding | 2.43 M | ||||
Shares Owned By Insiders | 54.68 % | ||||
Shares Owned By Institutions | 16.05 % | ||||
Number Of Shares Shorted | 57.18 K | ||||
Price To Earning | (4.19) X | ||||
Price To Sales | 3,631 X | ||||
Revenue | 9 K | ||||
Gross Profit | (9.93 M) | ||||
EBITDA | (25.41 M) | ||||
Net Income | (20.25 M) | ||||
Cash And Equivalents | 17.95 M | ||||
Cash Per Share | 0.22 X | ||||
Total Debt | 529 K | ||||
Debt To Equity | 0.08 % | ||||
Current Ratio | 3.12 X | ||||
Book Value Per Share | (11.84) X | ||||
Cash Flow From Operations | (18.52 M) | ||||
Short Ratio | 0.24 X | ||||
Earnings Per Share | (9.71) X | ||||
Target Price | 2.0 | ||||
Number Of Employees | 16 | ||||
Beta | 0.51 | ||||
Market Capitalization | 56.2 M | ||||
Total Asset | 11.02 M | ||||
Retained Earnings | (281.04 M) | ||||
Working Capital | 38 K | ||||
Current Asset | 52.12 M | ||||
Current Liabilities | 10.58 M | ||||
Z Score | 20.43 | ||||
Net Asset | 11.02 M |
About VTv Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VTv Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VTv Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VTv Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Return On Assets | (1.84) | (1.93) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out VTv Therapeutics Piotroski F Score and VTv Therapeutics Altman Z Score analysis. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of VTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.